Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion type Assertion NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_head.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion description "[In this study, the effect of increased MTHFS expression on the efficacy of the glycinamide ribonucleotide formyltransferase (GARFT) inhibitor LY309887 was investigated in SH-SY5Y neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion evidence source_evidence_literature NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion SIO_000772 19022216 NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion wasDerivedFrom befree-20140225 NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.
- NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_assertion wasGeneratedBy ECO_0000203 NP450596.RAKlfU_YLV9jEnkPwPXm8a09IcUw3Sa_-sU2T45-GbESc130_provenance.